title: Type 2 diabetes and cancer: what is the connection?
authors.affiliation: Mount Sinai School of Medicine, New York, NY, USA.
authors.forename: Dara
authors.initials: D
authors.lastname: Cannata
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Fierz
authors.forename: Archana
authors.initials: A
authors.lastname: Vijayakumar
authors.forename: Derek
authors.initials: D
authors.lastname: LeRoith
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology / Q000503:physiopathology*; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology*; D018450:Disease Progression; D005260:Female; D006801:Humans; D006946:Hyperinsulinism; D007328:Insulin; D007333:Insulin Resistance; D008297:Male; D010190:Pancreatic Neoplasms / Q000453:epidemiology / Q000503:physiopathology*; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000503:physiopathology*; D018570:Risk Assessment; D012307:Risk Factors; D013002:Somatomedins; D045162:Thiazolidinediones / Q000627:therapeutic use
chemical_list: D007328:Insulin; D013002:Somatomedins; D045162:Thiazolidinediones